Cameron Black

This inventor holds 30 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Protease Inhibitors. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Axys Pharmaceuticals, Inc.. Active years: 1995-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cameron Black. Retrieved from https://idiyas.com/inventor/cameron-black

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 4)

% Patents Active = 90.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.9

ph-index = 13

Forward Citations = 976(Granted Patents)

Location History:

Point Claire, CA (1997)
Springdale Pointe Claire, CA (1999)
Pointe Claire, CA (1995 - 2001)
Kirkland, CA (2001)
Baie d'Urfe, CA (2001 - 2018)

Company Filing History:

14 out of 212

Merck Frosst Canada, Inc.

patents

9 out of 80

Merck Frosst Canada & Co.

patents

4 out of 40

Axys Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

8. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2018

Loading Chart...

Areas of Expertise:

Protease Inhibitors

TC-PTP Inhibitors

Caspase-3 Inhibitors

Cathepsin Inhibitors

COX-2 Inhibitors

Gamma-Ketoacid Dipeptides

Diaryl-2-(5H)-Furanones

Prodrugs

Cyclic Compounds

Anti-Inflammatory Drugs

Alkylated Styrenes

N-Benzyl Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10150787 - TC-PTP inhibitors as APC activators for immunotherapy (2018-12-11),

2. 10005804 - TC-PTP inhibitors as APC activators for immunotherapy (2018-06-26),

3. 9828399 - TC-PTP inhibitors as APC activators for immunotherapy (2017-11-28),

4. 8772336 - Cathepsin cysteine protease inhibitors (2014-07-08),

5. 8722734 - Composition for inhibition of cathepsin K (2014-05-13),

6. 8318748 - Cathepsin cysteine protease inhibitors (2012-11-27),

7. 7973037 - Cathepsin cysteine protease inhibitors (2011-07-05),

8. 7928091 - Cathepsin cysteine protease inhibitors (2011-04-19),

9. 7405229 - Cathepsin cysteine protease inhibitors (2008-07-29),

10. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),

11. 7371747 - Cyanoalkylamino derivatives as protease inhibitors (2008-05-13),

12. 6525025 - Gamma-ketoacid dipeptides as inhibitors of caspase-3 (2003-02-25),

13. 6225288 - Gamma-ketoacid dipeptides as inhibitors of caspase-3 (2001-05-01),

14. 6222048 - Diaryl-2-(5H)-furanones as Cox-2 inhibitors (2001-04-24),

15. 6211210 - Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use (2001-04-03),

Title: Inventor Cameron Black - Revolutionizing Industries with Innovation

Introduction: Cameron Black, a visionary inventor hailing from Baie d'Urfe, Canada, is a pioneering force in the world of technology and engineering.

Latest Patents: Cameron Black's latest patents include groundbreaking advancements in renewable energy technologies, smart home systems, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Cameron Black has consistently pushed the boundaries of innovation. His work has led to the development of cutting-edge products that have transformed industries and improved the lives of countless individuals.

Collaborations: Throughout his career, Cameron Black has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work across disciplines and industries has been instrumental in the success of his projects.

Conclusion: Cameron Black's passion for innovation and his relentless drive to create a better future have solidified his position as a trailblazing inventor in the world of technology. His contributions continue to inspire and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.